SCHEMBL5013117

SCHEMBL5013117

CC(C)CCCOOC(=O)C=Cc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
LMNA P02545 4/20 0.48
TDP1 Q9NUW8 3/20 0.48
AKR1B10 O60218 2/20 0.47
AKR1B1 P15121 2/20 0.47
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
KMT2A Q03164 4/20 0.43
GLA P06280 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CYP2C9 P11712 3/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2C19 P33261 2/20 0.42
CYP3A4 P08684 1/20 0.42
MAPK1 P28482 1/20 0.42
MEN1 O00255 2/20 0.42
HDAC3 O15379 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5013109 1.00 ALDH1A1 (0.49) ALDH1A1LMNATDP1AKR1B10AKR1B1
SCHEMBL5013115 0.86 ALDH1A1 (0.61) ALDH1A1LMNATDP1AKR1B10AKR1B1
SCHEMBL28489568 0.85 AKR1B10 (0.44) ALDH1A1LMNATDP1AKR1B10AKR1B1
SCHEMBL23702410 0.84 BCHE (0.50) LMNATDP1AKR1B10AKR1B1KMT2A
SCHEMBL23702408 0.84 BCHE (0.50) LMNATDP1AKR1B10AKR1B1KMT2A
SCHEMBL1373613 0.82 LMNA (0.50) ALDH1A1LMNATDP1AKR1B10AKR1B1
SCHEMBL1373609 0.82 LMNA (0.50) ALDH1A1LMNATDP1AKR1B10AKR1B1
SCHEMBL28677409 0.82 EGFR (0.47) ALDH1A1LMNATDP1AKR1B10AKR1B1
SCHEMBL32073 0.82 EGFR (0.55) LMNAAKR1B10AKR1B1HDAC3
SCHEMBL16616720 0.82 ALDH1A1 (0.60) ALDH1A1LMNATDP1AKR1B10AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025133665-A1 OIL-IN-WATER EMULSION L V M H RECHERCHE (FR) 2025-06-26 WO disclosed
CN-118973541-A Improving the water resistance of a pigment-containing cosmetic composition 帝斯曼知识产权资产管理有限公司 2024-11-15 CN disclosed
EP-4452208-A1 AQUEOUS EMULSION L V M H RECHERCHE (FR) 2024-10-30 EP disclosed
WO-2023118912-A1 AQUEOUS EMULSION L V M H RECHERCHE (FR) 2023-06-29 WO disclosed
US-20230040911-A1 Oil-In-Water-Type Emulsion Cosmetic L V M H RECHERCHE (FR) 2023-02-09 US disclosed
EP-4076348-A1 OIL-IN-WATER-TYPE EMULSION COSMETIC L V M H RECHERCHE (FR) 2022-10-26 EP disclosed
WO-2021151452-A1 OIL-IN-WATER-TYPE EMULSION COSMETIC L V M H RECHERCHE (FR) 2021-08-05 WO disclosed
CN-106572960-B Compositions comprising microcapsules containing high-wet-point particles 欧莱雅 2021-06-18 CN disclosed
EP-3197563-B1 COMPOSITION BASED ON A LIPOPHILIC ORGANIC UV-SCREENING AGENT AND A FILLER OREAL (FR) 2019-10-30 EP disclosed
EP-3546025-A2 USE OF OLEOGELS IN UV ABSORBER COMPOSITIONS BASF SE (DE) 2019-10-02 EP disclosed
WO-2016030193-A1 COMPOSITION BASED ON A LIPOPHILIC ORGANIC SCREENING AGENT AND A FILLER L'OREAL (FR) 2016-03-03 WO disclosed
EP-2773201-A1 IMPROVED COMPOSITIONS Microdermis Corporation (US) 2014-09-10 EP disclosed
US-20130121953-A1 COMPOSITIONS MICRODERMIS CORPORATION (US) 2013-05-16 US disclosed
WO-2013066909-A1 IMPROVED COMPOSITIONS MICRODERMIS CORPORATION (US) 2013-05-10 WO disclosed
EP-1465587-B1 ANTIPERSPIRANT COMPOSITIONS UNILEVER PLC (GB) 2012-08-01 EP disclosed
US-20080131381-A1 METHODS FOR PHOTOSTABILIZING INGREDIENTS WITHIN COSMETICS, PERSONAL CARE AND HOUSEHOLD PRODUCTS AND COMPOSITIONS OBTAINED THEREFROM MERCK PATENT GESELLSCHAFT (DE) 2008-06-05 US disclosed
EP-1465587-A1 ANTIPERSPIRANT COMPOSITIONS UNILEVER PLC (GB) 2004-10-13 EP disclosed
US-6652843-B2 Containing fiber forming nonpolymeric structurant such as n-acyl aminoacid amide and/or cyclodipeptide UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. 2003-11-25 US disclosed
US-20030180240-A1 Clear solid suspension; molding material UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2003-09-25 US disclosed
WO-2003059308-A1 ANTIPERSPIRANT COMPOSITIONS UNILEVER PLC (GB) 2003-07-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230040911-A1 Oil-In-Water-Type Emulsion Cosmetic CUTA, PHOSPHO1, LIPE ALDH1A1 4132/4885LMNA 874/4885TDP1 1496/4885
US-20080131381-A1 METHODS FOR PHOTOSTABILIZING INGREDIENTS WITHIN COSMETICS, PERSONAL CARE AND HOUSEHOLD PRODUCTS AND COMPOSITIONS OBTAINED THEREFROM TYR, NISCH, PPOX ALDH1A1 742/4885LMNA 1693/4885TDP1 3083/4885
US-20030180240-A1 Clear solid suspension; molding material GRIA1, GLG1, GPR27 ALDH1A1 743/4885LMNA 3636/4885TDP1 923/4885
US-20130121953-A1 COMPOSITIONS POLE3, POLR1C, SSTR3 ALDH1A1 1482/4885LMNA 4634/4885TDP1 643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.